18. The Mechanisms and Therapeutic Consequences of Amine-Containing Drug Sequestration in Lysosomes

[1]  Dan Fu,et al.  Imaging the Intracellular Distribution of Tyrosine Kinase Inhibitors in Living Cells with Quantitative Hyperspectral Stimulated Raman Scattering , 2014, Nature chemistry.

[2]  J. Krise,et al.  Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study. , 2014, Journal of pharmaceutical sciences.

[3]  G. Koning,et al.  Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Krise,et al.  Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes. , 2013, Journal of pharmaceutical sciences.

[5]  Cheng-Chung Chang,et al.  Chemical principles for the design of a novel fluorescent probe with high cancer-targeting selectivity and sensitivity. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[6]  M. Forrest,et al.  Lysosomotropic Properties of Weakly Basic Anticancer Agents Promote Cancer Cell Selectivity In Vitro , 2012, PloS one.

[7]  J. Krise,et al.  Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction. , 2012, Molecular pharmaceutics.

[8]  Yvonne Will,et al.  A high content screening assay for identifying lysosomotropic compounds. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  P. Tripal,et al.  Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system , 2010, Journal of cellular physiology.

[10]  B. Samuelsson,et al.  The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K. , 2010, Bone.

[11]  M. Forrest,et al.  The Role of Lysosomes in Limiting Drug Toxicity in Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[12]  R. Rajewski,et al.  Mechanisms of amine accumulation in, and egress from, lysosomes. , 2009, Bioanalysis.

[13]  J. Kornhuber,et al.  Quantitative modeling of selective lysosomal targeting for drug design , 2008, European Biophysics Journal.

[14]  Xinyuan Zhang,et al.  Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines , 2008, J. Comput. Aided Mol. Des..

[15]  A. Bielawska,et al.  Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents. , 2008, Bioorganic & medicinal chemistry.

[16]  A. Bielawska,et al.  Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids. , 2008, Bioorganic & medicinal chemistry.

[17]  L. Duong,et al.  Effect of Cathepsin K Inhibitor Basicity on in Vivo Off-Target Activities , 2008, Molecular Pharmacology.

[18]  Jeffrey P Krise,et al.  Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. , 2007, Journal of pharmaceutical sciences.

[19]  Zhiyang Zhao,et al.  Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists , 2007, Pharmaceutical Research.

[20]  A. Bielawska,et al.  Tailoring structure-function and targeting properties of ceramides by site-specific cationization. , 2006, Bioorganic & medicinal chemistry.

[21]  M. Percival,et al.  The Consequences of Lysosomotropism on the Design of Selective Cathepsin K Inhibitors , 2006, Chembiochem : a European journal of chemical biology.

[22]  B. Blagg,et al.  A new approach for enhancing differential selectivity of drugs to cancer cells. , 2006, ACS chemical biology.

[23]  W. Weglicki,et al.  Iron Uptake and Release by Macrophages is Sensitive to Propranolol , 2006, Molecular and Cellular Biochemistry.

[24]  Richard W. Horobin,et al.  Fluorescent cationic probes for nuclei of living cells: why are they selective? A quantitative structure–activity relations analysis , 2006, Histochemistry and Cell Biology.

[25]  J. Krise,et al.  A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells. , 2005, Biochemistry.

[26]  J. Falgueyret,et al.  Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity. , 2005, Journal of medicinal chemistry.

[27]  Muralikrishna Duvvuri,et al.  A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. , 2005, Molecular pharmaceutics.

[28]  Malcolm Rowland,et al.  Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. , 2005, Journal of pharmaceutical sciences.

[29]  E. Arriaga,et al.  Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions. , 2005, Analytical chemistry.

[30]  Yaoquan Liu,et al.  Synthesis and biological activities of novel 17-aminogeldanamycin derivatives. , 2004, Bioorganic & medicinal chemistry.

[31]  S. Kellokumpu,et al.  Defective Acidification of Intracellular Organelles Results in Aberrant Secretion of Cathepsin D in Cancer Cells* , 2004, Journal of Biological Chemistry.

[32]  Muralikrishna Duvvuri,et al.  Weak Base Permeability Characteristics Influence the Intracellular Sequestration Site in the Multidrug-resistant Human Leukemic Cell Line HL-60* , 2004, Journal of Biological Chemistry.

[33]  J. Falgueyret,et al.  Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99. , 2004, Analytical biochemistry.

[34]  Muralikrishna Duvvuri,et al.  Separate Roles for the Golgi Apparatus and Lysosomes in the Sequestration of Drugs in the Multidrug-resistant Human Leukemic Cell Line HL-60* , 2003, Journal of Biological Chemistry.

[35]  A. Vandewalle,et al.  Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. , 2003, The Biochemical journal.

[36]  W. Daniel,et al.  Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping , 2001, British journal of pharmacology.

[37]  M. Roberts,et al.  Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. , 2001, The Journal of pharmacology and experimental therapeutics.

[38]  K. Yokogawa,et al.  Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs. , 2000, The Journal of pharmacology and experimental therapeutics.

[39]  M. Foley,et al.  Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. , 1998, Pharmacology & therapeutics.

[40]  S. Simon,et al.  Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy , 1998, The Journal of experimental medicine.

[41]  W. Daniel,et al.  Interactions between promazine and antidepressants at the level of cellular distribution. , 1997, Pharmacology & toxicology.

[42]  S. Simon,et al.  Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). , 1996, Biochemistry.

[43]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[44]  S. Simon,et al.  Cell biological mechanisms of multidrug resistance in tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Dubowchik,et al.  Reversal of doxorubicin resistance and catalytic neutralization of lysosomes by a lipophilic imidazole. , 1994, Biochimica et biophysica acta.

[46]  S. Simon,et al.  Intracellular pH and the control of multidrug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Lecerf,et al.  Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts. , 1992, The Journal of biological chemistry.

[48]  Thomas J. Raub,et al.  Primaquine blocks transport by inhibiting the formation of functional transport vesicles. Studies in a cell-free assay of protein transport through the Golgi apparatus. , 1991, The Journal of biological chemistry.

[49]  Richard W. Horobin,et al.  Predicting the behaviour and selectivity of fluorescent probes for lysosomes and related structures by means of structure-activity models , 1991, The Histochemical Journal.

[50]  E. Crivellato,et al.  Effect of lysosomotropic and membrane active substances on adriamycin uptake and histamine release. , 1990, Anticancer research.

[51]  A. Alcamí,et al.  The entry of African swine fever virus into Vero cells. , 1989, Virology.

[52]  M. Forgac.  Structure and function of vacuolar class of ATP-driven proton pumps. , 1989, Physiological reviews.

[53]  D. Cutler,et al.  The potential role of lysosomes in tissue distribution of weak bases , 1988, Biopharmaceutics & drug disposition.

[54]  W. Klohs,et al.  The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. , 1988, Molecular pharmacology.

[55]  H L Pearce,et al.  Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. , 1988, Molecular pharmacology.

[56]  D. Cutler,et al.  Role of lysosomes in hepatic accumulation of chloroquine. , 1988, Journal of pharmaceutical sciences.

[57]  G. Cramb,et al.  Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems. , 1986, Biochemical pharmacology.

[58]  M. Kobayashi,et al.  Lysosomotropic agents reverse multiple drug resistance in human cancer cells. , 1986, Cancer letters.

[59]  M. Hollingdale,et al.  Primaquine and lysosomotropic amines inhibit malaria sporozoite entry into human liver cells. , 1985, Molecular and biochemical parasitology.

[60]  K. von Figura,et al.  Tilorone acts as a lysosomotropic agent in fibroblasts. , 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[61]  E Griffiths,et al.  Cell killing by lysosomotropic detergents , 1983, The Journal of cell biology.

[62]  R. Draper,et al.  Monensin blocks the transport of diphtheria toxin to the cell cytoplasm , 1982, The Journal of cell biology.

[63]  B Poole,et al.  Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances , 1981, The Journal of cell biology.

[64]  P. Tulkens,et al.  Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. , 1978, European journal of cancer.

[65]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.

[66]  L. Mallucci,et al.  HISTOCHEMICAL STUDIES OF LYSOSOMES AND LYSOSOMAL ENZYMES IN VIRUS-INFECTED CELL CULTURES , 1965, The Journal of experimental medicine.

[67]  A. Allison,et al.  UPTAKE OF DYES AND DRUGS BY LIVING CELLS IN CULTURE. , 1964, Life sciences.

[68]  Greg J. Loewen,et al.  Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells) , 2013 .

[69]  E. Hempelmann,et al.  Erratum to: From methylene blue to chloroquine: A brief review of the development of an antimalarial therapy , 2012, Parasitology Research.

[70]  K. Schultz,et al.  The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease. , 1997, Leukemia & lymphoma.

[71]  A. Helenius,et al.  Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. , 1982, The Journal of general virology.